News for '-sohini-das'

Bajaj Chetak Takes the Slow Road To Global Reach

Bajaj Chetak Takes the Slow Road To Global Reach

Rediff.com15 Jan 2026

Bajaj Auto is planning a slow, calibrated push to take the Chetak, its electric scooter, to more than 100 countries on the strength of its distributor network and market-specific localisation rather than an aggressive global rollout, reports Sohini Das.

Mercedes-Benz Hits Speed Bump In 2025, Vows To Stay Course

Mercedes-Benz Hits Speed Bump In 2025, Vows To Stay Course

Rediff.com15 Jan 2026

Despite a 2.8 per cent fall in 2025 volumes, Mercedes-Benz India reported its best-ever revenue and profitability, led by top-end models, AMG growth and higher BEV mix.

'Medicines are just one part of the solution'

'Medicines are just one part of the solution'

Rediff.com21 May 2025

'We are looking at what kind of products, diagnostics or other solutions we can offer to become a well-rounded player in a particular disease area globally.'

MEA Pushes For Quick Resolution To China's Rare Earth Curbs

MEA Pushes For Quick Resolution To China's Rare Earth Curbs

Rediff.com13 Jun 2025

'We remain in touch with the Chinese side, in Beijing as well as in Delhi, to bring predictability in the supply chain.'

March blow for retail auto sales, may face headwinds

March blow for retail auto sales, may face headwinds

Rediff.com10 Apr 2025

The only silver lining in March's performance -- which otherwise dragged down the financial year's momentum -- was a 6 per cent year-on-year (Y-o-Y) growth compared to March of the previous year. This is largely due to incentives, festival-driven gains, and new launches.

'US tariff issue is an overhanging sword'

'US tariff issue is an overhanging sword'

Rediff.com7 Mar 2025

Firodia talked about his plans for the EV-components business, and the components business at large for the group

Budget: Auto cos eye 10m beneficiaries of no-tax rule

Budget: Auto cos eye 10m beneficiaries of no-tax rule

Rediff.com4 Feb 2025

According to experts, even if an additional 5 per cent of people opt to buy new vehicles, it may bring a huge boost to the sector.

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

EV launches, Chinese models... What Auto Expo Has In Store

EV launches, Chinese models... What Auto Expo Has In Store

Rediff.com17 Jan 2025

For the first time, the event will take place across three locations in Delhi: Bharat Mandapam at Pragati Maidan, Yashobhoomi Convention Centre at Dwarka, and India Expo Mart at Greater Noida.

This is one of the largest health-care deals in India

This is one of the largest health-care deals in India

Rediff.com13 Dec 2024

'Along with Blackstone, we would be keen to look at opportunities in the North.'

'Real growth and opportunity are going to come from GLP-1'

'Real growth and opportunity are going to come from GLP-1'

Rediff.com21 Aug 2024

'It is not just the US and European opportunity, but it is a huge global opportunity.'

Will Anna's Death Be A Wake-Up Call For India Inc?

Will Anna's Death Be A Wake-Up Call For India Inc?

Rediff.com8 Oct 2024

'In India, managers and the leadership almost glorify overworking.'

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

Rediff.com9 Aug 2024

'Mankind's experience, sharpness, and execution will make it happen. We are not going for short-term gains.'

'No question of bringing in an investor right now'

'No question of bringing in an investor right now'

Rediff.com24 Aug 2024

'We have got enough internal accruals, and we are able to do acquisitions on our own.'

'Depending on the product, the pricing pressure will always be there'

'Depending on the product, the pricing pressure will always be there'

Rediff.com3 Jun 2024

'That is a significant milestone for us and something we aspired for.'

'Electoral Bonds Not To Affect Lok Sabha Polls'

'Electoral Bonds Not To Affect Lok Sabha Polls'

Rediff.com26 Mar 2024

'Election funding needs a little more transparency.'

Can Ola Electric Cruise to 6,146 Cr IPO?

Can Ola Electric Cruise to 6,146 Cr IPO?

Rediff.com30 Jul 2024

The Softbank-backed company has set a price band of Rs 72 to Rs 76 per share for the maiden share sale and is expected to test the appetite for new-age loss-making companies.

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Are hospitals ready to handle Covid surge?

Are hospitals ready to handle Covid surge?

Rediff.com26 Dec 2023

Larger hospitals are not worried about a spike in cases, as they are now accustomed to converting ICUs and general wards into negative pressure zones or isolation rooms. For smaller hospitals, the task is tedious.

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Rediff.com28 Dec 2023

As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.

India Inc capital expenditure story gets cement to semiconductor push

India Inc capital expenditure story gets cement to semiconductor push

Rediff.com19 Apr 2024

Corporate India is starting to step up its capital expenditure plans amid government incentives and signs of rising demand, company executives and analysts have indicated. This coincides with the Reserve Bank of India (RBI) recently citing a double-digit growth in private capital expenditure. Healthy balance sheets of banks and corporates, along with increasing capacity utilisation and improving business sentiment, are contributing to a favourable environment for sustained growth in private sector investments, the RBI said in its policy last week.

Does India have enough vaccine reserves to combat another Covid wave?

Does India have enough vaccine reserves to combat another Covid wave?

Rediff.com27 Dec 2023

According to CoWIN data, only 73 vaccination centres are currently active in India, of which 32 are government-run.

'Second-gen promoters more open to selling out'

'Second-gen promoters more open to selling out'

Rediff.com6 Jun 2024

'There is not any negative connotation associated with it.'

'Black swan events are becoming increasingly frequent'

'Black swan events are becoming increasingly frequent'

Rediff.com6 Nov 2023

If the war in the Israel-Gaza region escalates into a larger West Asian conflict, it could pose problems.

'APIs are a very strategic part of Biocon's business'

'APIs are a very strategic part of Biocon's business'

Rediff.com7 Jan 2024

'There is no reason why we should break this business up.'

'Need to make Auto Exports a national mission'

'Need to make Auto Exports a national mission'

Rediff.com26 Sep 2023

'There is a need for a national task force with a singular objective to increase automotive exports.'

Nigeria flags 2 India-made drugs as substandard, having toxins

Nigeria flags 2 India-made drugs as substandard, having toxins

Rediff.com20 Jun 2023

Oral paracetamol and another cough medicine manufactured by companies based in Mumbai and Punjab were found to be "sub-standard or found to be containing toxins", reports Sohini Das.

Govt in talks with SII for Nipah antibody, may put imports on hold

Govt in talks with SII for Nipah antibody, may put imports on hold

Rediff.com21 Sep 2023

Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies for treating Nipah virus infections and is in talks with Serum Institute of India, report Shine Jacob and Sohini Das.

'Aster DM's plan is to be among top three in India'

'Aster DM's plan is to be among top three in India'

Rediff.com27 Jan 2024

'Now that we are a pure-play India business, many investors are open to investing.'

India's Big Guns Firing On Capex Front

India's Big Guns Firing On Capex Front

Rediff.com13 Feb 2024

'Interim Budget has ignited the entrepreneurial spirit.'

'The formulations business been a growth driver'

'The formulations business been a growth driver'

Rediff.com24 Feb 2024

'However, we have seen weakness in our active pharmaceutical ingredients business.'

Soaring veggie prices stoke inflation fears

Soaring veggie prices stoke inflation fears

Rediff.com12 Jul 2023

Unprecedented rains and floods in the northern region in the past few days have not only caused extensive damage to lives and property but have also impacted business and commercial establishments. Vegetable prices have gone through the roof in the national capital and many other parts of the country since rains started pouring earlier this month. Traders say vegetable prices would come down only after roads open and skies clear, even as water in the fields will take time to recede.

A COVID-19 Vaccine Snapshot

A COVID-19 Vaccine Snapshot

Rediff.com28 Apr 2021

Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria.

'Mercedes To Launch 10 Cars In 2023'

'Mercedes To Launch 10 Cars In 2023'

Rediff.com3 Jul 2023

'And a majority will be in the top-end vehicle range.'

93% CEOS Plan To Hire More Employees

93% CEOS Plan To Hire More Employees

Rediff.com12 Apr 2023

Many CEOs said they plan to give special leave to women employees so as to encourage their participation in the workforce.

Gujarat gets lion's share of Covid vaccines

Gujarat gets lion's share of Covid vaccines

Rediff.com4 May 2021

Delhi, which has been one of the worst affected states, accounted for less than two per cent of total vaccinations in the 18-44 age-group.

'A creative mind never ages'

'A creative mind never ages'

Rediff.com26 Jan 2023

Balkrishna V Doshi, who won the Pritzker Award in 2018 -- which is equivalent to the Nobel Prize in architecture -- passed into the ages this week. Sohini Das recalls an encounter with the the legendary architect, who was posthumously awarded the Padma Vibhushan in this year's Republic Day honours list.

Why electric two-wheelers missed the ambitious 1 million sales target

Why electric two-wheelers missed the ambitious 1 million sales target

Rediff.com1 Mar 2023

With just a month left in this financial year, electric two-wheeler sales, so far, are at just 62 per cent of the ambitious target of 1 million units set for 2022-23 by the NITI Aayog. According to VAHAN data, compiled by the Society of Manufacturers of Electric Vehicles (SMEV), 620,006 units of electric two-wheelers were sold across the country in FY23 until February 21. Though the industry may miss the 1-million target, sales in FY23 are already up 146 per cent from 249,621 units sold in FY22.

Capex tops India Inc's 2023 to-do list

Capex tops India Inc's 2023 to-do list

Rediff.com9 Jan 2023

Indian companies are planning to increase investments in the new year to expand capacity, acquire companies, and go on a hiring spree, a survey of top executives showed. They, however, cited rising costs, weak consumer demand, and increasing interest rates as major concerns for 2023 which may impact their plans.